Phthalazinone derivatives

Details for Australian Patent Application No. 2008299721 (hide)

Owner Astrazeneca AB

Inventors Menear, Keith Allan; Javaid, Muhammad Hashim; Martin, Niall Morrison Barr

Agent Shelston IP

Pub. Number AU-A-2008299721

PCT Pub. Number WO2009/034326

Priority 60/972,384 14.09.07 US; 61/032,642 29.02.08 US

Filing date 12 September 2008

Wipo publication date 19 March 2009

International Classifications

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 March 2010 PCT application entered the National Phase

  PCT publication WO2009/034326 Priority application(s): WO2009/034326

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008299744-Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase CDC25 inhibitors

2008299717-Wound dressing with apertured cover sheet